Diagnosis and management of axial spondyloarthritis in primary care

Ankylosing spondylitis is a relatively uncommon inflammatory...

August 2016

Biosimilars - what does a primary care clinician need to know?

”Biosimilars” is likely to become an increasingly familiar term...

October 2015

The New Zealand Laboratory Schedule and Test Guidelines: genetic tests

The New Zealand Laboratory Schedule provides clinicians with...

November 2014

Safer prescribing of high-risk medicines - Methotrexate: potentially fatal in overdose

Low-dose methotrexate is commonly used in the treatment of patients...

October 2014

Investigating myalgia in patients taking statins

Muscle pain (myalgia) and weakness is experienced by up to 10%...

August 2014

Gout update: Febuxostat now subsidised on Special Authority

Febuxostat was added to the New Zealand Pharmaceutical Schedule...

July 2014

A conversation about gout…

In New Zealand, the majority of people with gout have higher...

April 2014

Measuring serum urate levels

Gout is a common form of inflammatory arthritis that is caused...

April 2014

Biologic medicines for the treatment of inflammatory conditions: What does primary care need to know?

Patients with severe immune-mediated inflammatory diseases,...

December 2013

Non-steroidal anti-inflammatory drugs (NSAIDs): Making safer treatment choices

Non-steroidal anti-inflammatory drugs (NSAIDs) are successfully...

October 2013

Calcium pyrophosphate deposition disease: The arthropathy formerly known as “Pseudogout”

A number of clinical syndromes are associated with the precipitation...

October 2013

Giant cell arteritis: Always keep it in your head

Giant cell arteritis, also referred to as temporal arteritis,...

June 2013

Polymyalgia rheumatica: Look before you leap

Polymyalgia rheumatica is an inflammatory condition that causes...

June 2013

An update on the management of gout

The management of gout involves treatment of an acute attack,...

March 2013

The medical management of gout revisited

Gout has a significant impact on Māori in New Zealand. Management...

August 2011

Gout: an alarm bell for diabetes and cardiovascular disease

Counties Manukau DHB Māori Gout Action Group have identified...

August 2011

Genes, fructose, allopurinol and gout

A short article on gout with specific reference to Pacific...

November 2010

TNF inhibitors - an update

Tumour necrosis factor (TNF) inhibitors are used in the treatment...

November 2009

Prevention of osteoporosis

Osteoporosis and subsequent fracture may be prevented by maintaining...

October 2008

Symptomatic management of osteoarthritis

The key treatment of osteoarthritis is to provide information...

October 2008

Rheumatoid arthritis - monitoring of DMARDs

Most people with rheumatoid arthritis require early treatment...

October 2008

Update: Gout in the Māori community

Gout is a significant health issue for Māori. This article...

May 2008

Gout - Hit the target

Gout is an arthritis caused by the inflammatory response to...

September 2007

Dear Dave

What is the significance of the warning between ACE inhibitors...

June 2007

CRP vs ESR: Reminder

A summary of the key messages from this campaign and changes...

May 2007

Best Tests: ANA testing.

Diabetes tests plus:
• ANA testing.

June 2006

Best Tests: CRP vs ESR

CRP vs ESR Plus:
• Drug tests for drink spiking
• Cervical smear...

September 2005

CRP vs ESR Assessing and measuring the inflammatory response

Discussion of the use of CRP and ESR as tests of the inflammatory...

July 2005

Made with by the bpacnz team